News

Featured Story

2025 Research Updates

Research is the answer to one day making FA a treatable, manageable disease. Here, you'll discover the most recent strides in FA research and activities funded by FCF. Every quarter, we'll bring you updates on newly funded grants, ongoing projects, and significant milestones.

Adulting with Fanconi Anemia

We first learned something was wrong in 2004. I was a normal, healthy kid until I went to my pediatrician for my 13-year-old booster shot and blood draw. That was the first sign something was off. After a bone marrow...

Read More >

How might we apply cancer-fighting strategies from the general population to the FA population?

To fast-track therapies for people with Fanconi anemia (FA), it’s often best to start by examining progress that’s already been made in the general population. Large-scale studies such as The Cancer Genome Atlas (TCGA) have made it possible to detect...

Read More >

Nunca más huérfana

Introducción Mi especialidad empezó en 1927 como huérfana. Sin tener ninguna relación con nada conocido hasta entonces y sin conexiones a una comunidad mas amplia, lo que siguieron son 60 anos de abandono. En 1985, una valiente familia decidió que...

Read More >

News from the lab: the FA pathway and fertility

An update for FA families In the March 2019 issue of Trends in Genetics, researchers from St. Vincent’s Institute in Australia published a paper on the FA pathway and fertility. We asked the authors to provide a summary for FA families....

Read More >

Update: the FANCA Gene Therapy Trial

The global Fanconi anemia gene therapy program is now open in the USA and Europe. In Europe, a new study, known as FANCOLEN-2, is available at CIEMAT/Hospital del Niño Jesús in Madrid, Spain. In the USA, a similar study is now...

Read More >

Could anticancer drugs work in FA?

People with Fanconi anemia (FA) have a 500- to 700-fold increased risk of developing head and neck squamous cell carcinoma (HNSCC) tumors when compared to the general population. Conventional treatments available for non-FA-HNSCC such as radiation therapy and chemotherapy are...

Read More >